SCHEMBL8013240

SCHEMBL8013240

[CH2]c1ccc(N(CCCCCCC)C(=O)c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.55
NPC1 O15118 1/20 0.55
JAK2 O60674 1/20 0.55
RAB9A P51151 1/20 0.55
PAX8 Q06710 1/20 0.55
ALDH1A1 P00352 4/20 0.51
ADRB2 P07550 1/20 0.51
MAPT P10636 1/20 0.48
STAT3 P40763 1/20 0.46
TSHR P16473 1/20 0.44
CNR2 P34972 1/20 0.43
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
PTGIR P43119 1/20 0.43
PDE10A Q9Y233 1/20 0.43
NAAA Q02083 1/20 0.42
TP53 P04637 1/20 0.42
PTGES O14684 2/20 0.42
ALOX5 P09917 2/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15291404 0.90 ADRA2C (0.67) ADRA2CNPC1JAK2RAB9APAX8
SCHEMBL9001628 0.84 ADRA2C (0.71) ADRA2CNPC1JAK2RAB9APAX8
SCHEMBL6543542 0.83 ADRA2C (0.55) ADRA2CNPC1JAK2RAB9APAX8
SCHEMBL8016862 0.83 ADRA2C (0.55) ADRA2CNPC1JAK2RAB9APAX8
SCHEMBL11506563 0.81 ADRA2C (0.58) ADRA2CNPC1JAK2RAB9APAX8
SCHEMBL8012983 0.78 PTGIR (0.55) ADRA2CNPC1RAB9AALDH1A1TSHR
SCHEMBL9001626 0.77 ADRA2C (0.65) ADRA2CNPC1JAK2RAB9APAX8
SCHEMBL15766207 0.76 NPC1 (0.68) ADRA2CNPC1JAK2RAB9APAX8
SCHEMBL10961189 0.76 NPC1 (0.71) ADRA2CNPC1JAK2RAB9APAX8
SCHEMBL10960608 0.76 NPC1 (0.71) ADRA2CNPC1JAK2RAB9APAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1066729-C Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-06-06 CN disclosed
CN-1060173-C Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 2001-01-03 CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
CN-1157288-A Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-08-20 CN disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
CN-1118781-A Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 1996-03-20 CN disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed